Page last updated: 2024-11-03

prazosin and Appetite Disorders

prazosin has been researched along with Appetite Disorders in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research Excerpts

ExcerptRelevanceReference
"Prazosin pretreatment at 2."1.32Noradrenergic modulation of ephedrine-induced hypophagia. ( Ho, DH; Miller, DK; Wellman, PJ, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hicks, C1
Sabino, V1
Cottone, P1
Wellman, PJ1
Miller, DK1
Ho, DH1

Other Studies

2 other studies available for prazosin and Appetite Disorders

ArticleYear
The Alpha-1 Adrenergic Receptor Antagonist Prazosin Reduces Binge-Like Eating in Rats.
    Nutrients, 2020, May-28, Volume: 12, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Disease Models, Animal; Feeding and Eating Disorde

2020
Noradrenergic modulation of ephedrine-induced hypophagia.
    Synapse (New York, N.Y.), 2003, Volume: 48, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Central Nervous System Stimulants; Dopamine; Ephedrine; Feedi

2003